- Home
- Publications
- Publication Search
- Publication Details
Title
Emerging drugs for the treatment of Dravet syndrome
Authors
Keywords
-
Journal
EXPERT OPINION ON EMERGING DRUGS
Volume 23, Issue 4, Pages 261-269
Publisher
Informa UK Limited
Online
2018-11-28
DOI
10.1080/14728214.2018.1552937
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment Strategies for Dravet Syndrome
- (2018) Kelly G. Knupp et al. CNS DRUGS
- Development and content validation of a preliminary core set of patient- and caregiver-relevant outcomes for inclusion in a potential composite endpoint for Dravet Syndrome
- (2018) Rima Nabbout et al. EPILEPSY & BEHAVIOR
- Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome
- (2018) Orrin Devinsky et al. NEUROLOGY
- Prospective study of the efficacy of a ketogenic diet in 20 patients with Dravet syndrome
- (2018) Ni Yan et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Selective NaV1.1 activation rescues Dravet syndrome mice from seizures and premature death
- (2018) Kay L. Richards et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dravet syndrome: Characteristics, comorbidities, and caregiver concerns
- (2017) Nicole Villas et al. EPILEPSY & BEHAVIOR
- Not all SCN1A epileptic encephalopathies are Dravet syndrome
- (2017) Lynette G. Sadleir et al. NEUROLOGY
- Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
- (2017) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Optimizing the Diagnosis and Management of Dravet Syndrome: Recommendations From a North American Consensus Panel
- (2017) Elaine C. Wirrell et al. PEDIATRIC NEUROLOGY
- Pharmacological Analysis of the Anti-epileptic Mechanisms of Fenfluramine in scn1a Mutant Zebrafish
- (2017) Jo Sourbron et al. Frontiers in Pharmacology
- Unexpected Efficacy of a Novel Sodium Channel Modulator in Dravet Syndrome
- (2017) Lyndsey L. Anderson et al. Scientific Reports
- Serotonergic Modulation as Effective Treatment for Dravet Syndrome in a Zebrafish Mutant Model
- (2016) Jo Sourbron et al. ACS Chemical Neuroscience
- Efficacy of antiepileptic drugs for the treatment of Dravet syndrome with different genotypes
- (2016) Xiu-Yu Shi et al. BRAIN & DEVELOPMENT
- Low-dose fenfluramine significantly reduces seizure frequency in Dravet syndrome: a prospective study of a new cohort of patients
- (2016) A. Schoonjans et al. EUROPEAN JOURNAL OF NEUROLOGY
- The European patient with Dravet syndrome: Results from a parent-reported survey on antiepileptic drug use in the European population with Dravet syndrome
- (2015) Luis Miguel Aras et al. EPILEPSY & BEHAVIOR
- Efficacy and tolerability of the ketogenic diet in Dravet syndrome – Comparison with various standard antiepileptic drug regimen
- (2015) Anastasia Dressler et al. EPILEPSY RESEARCH
- The possible use of the L-type calcium channel antagonist verapamil in drug-resistant epilepsy
- (2015) Francesco Nicita et al. Expert Review of Neurotherapeutics
- The possible use of the L-type calcium channel antagonist verapamil in drug-resistant epilepsy
- (2015) Francesco Nicita et al. Expert Review of Neurotherapeutics
- Low-dose fenfluramine in the treatment of neurologic disorders: experience in Dravet syndrome
- (2015) An-Sofie Schoonjans et al. Therapeutic Advances in Neurological Disorders
- Lamotrigine can be beneficial in patients with Dravet syndrome
- (2014) Linda Dalic et al. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
- (2014) Orrin Devinsky et al. EPILEPSIA
- Pharmacodynamic interaction between stiripentol and benzodiazepines: From molecular to clinical studies
- (2013) Francesco Brigo EPILEPSY & BEHAVIOR
- When one plus one makes three: The quest for rational antiepileptic polytherapy with supraadditive anticonvulsant efficacy
- (2013) Francesco Brigo et al. EPILEPSY & BEHAVIOR
- Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy
- (2013) Brenda E. Porter et al. EPILEPSY & BEHAVIOR
- Encephalopathy in children with Dravet syndrome is not a pure consequence of epilepsy
- (2013) Rima Nabbout et al. Orphanet Journal of Rare Diseases
- Efficacy of verapamil as an adjunctive treatment in children with drug-resistant epilepsy: A pilot study
- (2013) Francesco Nicita et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Successful use of fenfluramine as an add-on treatment for Dravet syndrome
- (2012) Berten Ceulemans et al. EPILEPSIA
- Bromide in Patients with SCN1A-Mutations Manifesting as Dravet Syndrome
- (2012) Jan Lotte et al. NEUROPEDIATRICS
- Specific deletion of NaV1.1 sodium channels in inhibitory interneurons causes seizures and premature death in a mouse model of Dravet syndrome
- (2012) C. S. Cheah et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neuroimaging and neuropathology of Dravet syndrome
- (2011) Renzo Guerrini et al. EPILEPSIA
- The ketogenic diet for Dravet syndrome and other epileptic encephalopathies: An Italian consensus
- (2011) Pierangelo Veggiotti et al. EPILEPSIA
- The core Dravet syndrome phenotype
- (2011) Charlotte Dravet EPILEPSIA
- Low long-term efficacy and tolerability of add-on rufinamide in patients with Dravet syndrome
- (2011) A. Mueller et al. EPILEPSY & BEHAVIOR
- Electroencephalographic Features in Dravet Syndrome
- (2011) Nicola Specchio et al. JOURNAL OF CHILD NEUROLOGY
- Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005-2009
- (2010) Anne T. Berg et al. EPILEPSIA
- Clinical course of young patients with Dravet syndrome after vagal nerve stimulation
- (2010) Nelia Zamponi et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- SCN1Aduplications and deletions detected in Dravet syndrome: Implications for molecular diagnosis
- (2009) Carla Marini et al. EPILEPSIA
- Comment to: Addition of verapamil in the treatment of severe myoclonic epilepsy in infancy (Iannetti et al.)
- (2009) Pasquale Striano EPILEPSY RESEARCH
- Addition of verapamil in the treatment of severe myoclonic epilepsy in infancy
- (2009) Paola Iannetti et al. EPILEPSY RESEARCH
- A CACNB4 mutation shows that altered Cav2.1 function may be a genetic modifier of severe myoclonic epilepsy in infancy
- (2008) Iori Ohmori et al. NEUROBIOLOGY OF DISEASE
- The anti-convulsant stiripentol acts directly on the GABAA receptor as a positive allosteric modulator
- (2008) Janet L. Fisher NEUROPHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started